Cite
HARVARD Citation
Bottlaender, L. et al. (2020). Cutaneous adverse events: a predictor of tumour response under anti‐PD‐1 therapy for metastatic melanoma, a cohort analysis of 189 patients. Journal of the European Academy of Dermatology and Venereology. pp. 2096-2105. [Online].